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Abstract: Background: Gagging during transesophageal echocardiography examination (TEE) can
be distressing and even dangerous for patients. The needling of acupuncture point CV24 was
described to be effective in reducing the gag reflex during TEE in patients with ischemic stroke or
transient ischemic attack. Methods: We describe a proposal for a prospective, randomized, patient,
practitioner and assessor-blinded, single-center trial with two arms/groups; real acupuncture will
be compared to placebo acupuncture. A total of 60 (30 per group) patients scheduled for elective
TEE in order to exclude a cardiac embolic source, endocarditis or for valve failure evaluation will
be recruited according to patients’ selection criteria and receive either indwelling fixed intradermal
needles at acupoints CV24 and bilateral PC6 or placebo needles at the same areas. Patients, the
practitioners who will perform the TEE procedure, and the assessor of the outcome measures will be
unaware of the group’s (real or placebo) allocation. Results: The primary outcome is the intensity
of gagging, measured using verbal rating scale (VRS-11) from 0 = no gagging to 10 = intolerable
gagging. Secondary outcomes include the incidence of gagging, the use of rescue medication, patients’
satisfaction with relief of unwanted side effects during TEE procedure, success of patients’ blinding
(patients’ opinion to group allocation), heart rate and oxygen saturation measured by pulse oxymetry.
Conclusions: To study the effects of acupuncture against gagging during TEE, we test the needling
of acupoints CV24 and PC6 bilaterally. A placebo acupuncture is used for the control group. Trial
registration number: NCT NCT0382142.
Keywords: transesophageal echocardiography; gag reflex; acupuncture
1. Introduction
The gag reflex is a part of a normal defense mechanism, intended to prevent unwanted, irritating,
or toxic material or fluids from entering the trachea, pharynx or larynx. It is a polysynaptic reflex,
which arises at the cortical level and is composed of a palatal and a pharyngeal response. Palatal
response comprises an upward movement of the soft palate with an ipsilateral deviation of the uvula,
whereas the pharyngeal response means the contraction of the pharyngeal wall [1,2]. Concomitant
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features include salivation, eye watering, coughing, sweating, head withdrawal, fainting or even a
panic attack [3]. The gag reflex can be stimulated by touching trigger areas like the posterior pharyngeal
wall, tonsillar area, and the base of the tongue, palate and uvula.
With the growing number of diagnostic and therapeutic procedures where manipulation in the
pharyngeal area is necessary (e.g., with fiberoptic probes), gagging became a common clinical problem,
with an incidence of more than 40% despite use of local anesthesia and sedation [4,5]. Gagging makes
diagnostic and therapeutic procedures distressing and often difficult or even impossible to perform.
Various interventions are used to control the gag reflex, for example, antiemetic medication, sedatives,
local and general anesthetics, herbal remedies, behavioral therapies, acupressure, acupuncture, and
prosthetic devices; however, there is no evidence favoring any specific treatment of the gag reflex in
clinical conditions [5].
The needling of acupuncture points CV24 and PC6 (Figure 1), is suggested as a complementary or
even alternative option for the treatment of gagging and concomitant nausea during various medical
procedures [6–11].
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Acupuncture of CV24 and PC6 is commonly used to alleviate the gag reflex in dentistry in
adult and in pediatric patients. However, the effectiveness of acupuncture for this condition was
suggested on the basis of several pilot case series or non-robust experimental investigations [6,7,10,11].
Beyond dentistry, the needle stimulation of acupoint CV24 was suggested to be effective for suppressing
the gag reflex in patients with ischemic stroke or transient ischemic attack undergoing transesophageal
echocardiography (TEE) [9]. In this pilot investigation, acupuncture was superior to a sham procedure,
was easy to apply and effective in reducing the gag reflex during TEE.
We are going to evaluate whether adding acupuncture to current clinical standards in reducing
gag reflex in patients undergoing diagnostic TEE is a secure, effective and easy-to-use method. For this
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purpose, we will compare the acupuncture of CV24 and PC6 with a placebo procedure in a two-arm
randomized controlled investigation, where the patients, cardiologists and outcome assessors will be
blinded to group allocation.
2. Materials and Methods
2.1. Study Design
This investigation is a prospective randomized, patient, practitioner and assessor-blinded,
single-center trial at the University Medicine of Greifswald with two arms/groups: real acupuncture
will be compared to placebo acupuncture. The total duration of the investigation for each patient is
approximately 30 min. A total of 60 (30 per group) patients scheduled for elective transesophageal
echocardiography (TEE) will be recruited according to patients’ selection criteria. TEE is performed in
preparation for an electrophysiological procedure, to exclude a cardiac embolic source or endocarditis
or for valve failure evaluation. Patients, the practitioners who perform the TEE procedure and the
assessor of the outcome measures, are unaware (“blinded”) regarding the group allocation. Only the
acupuncturist, who performs the randomization, will know the group allocation. The local ethics
committee approved the protocol of the investigation. The schedule of enrolment, interventions and
assessment is given in the Supplementary Figure S1 according to SPIRIT recommendations
2.2. Eligibility Criteria
Patients between 19 and 65 years old with an American Society of Anesthesiologists physical
status of I to III, scheduled for elective ambulatory transesophageal echocardiography (TEE) without
sedation, without previous opioid and psychotropic medication, who were able to use the verbal rating
scale 0–10 (VRS-11) were recruited in this investigation. Patients who were unable to give the written
informed consent or had a skin infection at the sites of acupuncture or reported a history of psychiatric
disease, radio- or chemotherapy or peripheral polyneuropathy were not included. Patients with a
congenital absence of gag reflex and pregnant women were not included in this investigation. The data
of patients where the usual TEE schedule had to be changed or who developed severe complications
during the investigation were excluded from the final analysis.
2.3. Group Allocation and Randomization
During the standard pre-procedural examination, the patients, screened according to eligibility
criteria (s. above), will be informed about the possibility to receive either real acupuncture (RA) or
placebo acupuncture (PA) by chance in addition to standard therapy for relief of the gag reflex during
TEE and will be asked if they would like to take part in the investigation. If they agree, they will have
to sign their informed consent and will be randomly allocated to RA (30 patients) or PA (30 patients)
prior to the TEE procedure (Figure 1).
The acupuncturist will perform the allocation procedure using the
randomly-generated-by-computer list of numbers 1 and 2: the patients who will receive RA
will be assigned to one of two numbers; one number represents the RA group and the other represents
placebo. The randomization is concealed from patients and practitioners; only the acupuncturist will
be aware of the group allocation.
2.4. Current Standard Treatment for TEE Procedure
According to our hospital standard operating procedure for TEE preparation, all patients will
receive three puffs (approximately 30 mg) of 10 % lidocaine pump spray (Astra Zeneca) prior to
acupuncture/placebo acupuncture and TEE procedure. In case the gag intensity reaches 10 points
on VRS-11 and the insertion of TEE probe is impossible, midazolam 1–2 mg will be administered
intravenously. If the maximal dose of 5 mg midazolam is reached and the patient still experiences
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gagging, which precludes the insertion of the TEE probe, than incremental doses of 10 mg propofol as
a rescue medication will be allowed until the TEE probe is inserted.
2.5. Study Procedure
In the RA group, the acupuncturist will apply the needles to Chengjiang CV24 and both Neiguan
PC6 (bilaterally) acupuncture points prior to the TEE procedure. Acupoint PC6 is situated on the
medial side of the lower arm between the tendons of M. flexor carpi radialis and M. palmaris longus
3–4 cm over the wrist crease (Figure 2).
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Figure 2. (A) Acupoint Neuguan PC6 is situated on the medial side of the lower arm between the
tendons of M. flexor carpi radialis and M. palmaris longus 3–4 cm over the wrist crease; (B) disposable
indwelling acupuncture New Pyonex needle (black arrow) with a diameter 0.2 and length 1.5 mm,
embedded in skin-colored adhesive tape, over the acupoint PC6. (C) New Pyonex needle in situ. White
plastic hemisphere is seen over the round adhesive tape (white arrows).
Medicines 2020, 7, 17 5 of 9
Acupoint CV24 is situated on the ventral midline in a mento-labial groove (Figure 3).
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The choice of acupuncture points is based on the findings from previous investigations on the
treatment of gagging in patients during medical procedures [6–11] and was performed according to
Standard for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) recommendations
(Table 1) [12].
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Table 1. Interventions details by Standards for Reporting Interventions in Clinical Trials of Acupuncture
(STRICTA) items.
Item Detailed Items Description
1. Acupuncture
rationale
1a) Style of acupuncture
1b) Reasoning for treatment provided based on
historical context, literature sources, and/or
consensus methods, with references where
appropriate
1c) Extent to which treatment was varied
Western medical acupuncture
Acupuncture methods described
as effective in previous pilot
investigations (references [6–11])
Standardized acupuncture for each
patient, no individual variation
2. Details of
needling
2a) Number of needle insertions per subject per
session (mean and range where relevant)
2b) Names (or location if no standard name) of
points used (uni/bilateral)
2c) Depth of insertion, based on a specified unit
of measurement or on a particular tissue level
2d) Response sought
2e) Needle stimulation
2f) Needle retention time
2 g) Needle type (diameter, length, and
manufacturer or material)
Three intradermal needles
Chengjiang (CV24) midline
acupoint
Neiguan (PC6) bilateral
5 mm at CV24;
1.5 mm at PC6
No response sought
No needle stimulation
Until the end of TEE (max. 30 min)
Intradermal “Spinex” needle (0.14
mm × 6 mm, Seirin Corp. Japan)
at CV24;
indwelling ear acupuncture “New
Pyonex” needle (0.2 mm × 1.5 mm,
Seirin Corp. Japan) at PC6
3. Treatment
regimen
3a) Number of treatment sessions
3b) Frequency and duration of treatment sessions
One session
Once for each patient
4. Other
components of
treatment
4a) Details of other interventions administered to
the acupuncture group
4b) Setting and context of treatment, including
instructions to practitioners, and information and
explanations to patients
None
Each patient will be informed
about acupuncture or placebo
procedure against gagging during
TEE 1
5. Practitioner
background
5) Description of participating acupuncturists
(qualification or professional affiliation, years in
acupuncture practice, other relevant experience)
Licensed medical acupuncturist
with more than 10 years of
acupuncture practice
6. Control of
comparator
interventions
6a) Rationale for the control or comparator in the
context of the research question, with sources that
justify this choice
6b) Precise description of the control or
comparison group. If sham acupuncture or any
other type of acupuncture-like control is used,
provide details as for items 1 to 3, above
To study the efficacy and safety of
acupuncture as an additional
therapy in the relief of gagging
during a routine TEE procedure
Placebo needles will be placed
over the same sites in patients
from the control group as in the
acupuncture group
1 TEE: transesopageal echocardiography.
For the acupuncture of PC6 points, disposable indwelling acupuncture New Pyonex needles
(diameter 0.2 and length 1.5 mm, manufactured by Seirin Corp., Shizuoka, Japan) embedded in
skin-colored adhesive tape will be used (Figure 2B,C). Acupuncture of point CV24 will be done using
disposable intradermal “Spinex” needles (diameter 0.14 mm and length 6 mm; Seirin Corp., Shizuoka,
Japan, Figure 3B). the Spinex needle will be inserted and its loop, which remains on the surface of the
skin (Figure 3C), will be attached using New Pyonex Placebo needles (Figure 3D). A New Pyonex
Placebo needle, which was designed for a placebo control procedure in auricular acupuncture studies,
has the same appearance as the New Pyonex needle but consists of self-adhesive tape only, without the
needle itself (Figure 3C).
In patients who are assigned to the PA group, the acupuncturist will apply the New Pyonex
placebo needles to the same areas where the needles for RA would be inserted. In order to provide the
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feeling of “pricking” during the application of New Pyonex placebo needles, the skin areas around
acupuncture points will be examined using the using SVESA neural pen (Neuralstift SVESA 1070,
SVESA, Muenchen, Germany). The SVESA neural pen is commonly used in acupuncture practice for
the identification of skin areas with lower skin resistance, which are attributed to acupuncture points,
as was described elsewhere [13]. The neural pen has a thin tip, which produces the feeling of needle
insertion, if certain pressure is applied to the skin. Acupuncturist will tell the patients from PA group
that he is using the neural pen “to find” the acupuncture points, however he will use it to produce a
pressure with the tip of neural pen (resembling the pricking of the needle) and attach New Pyonex
placebo needles at the areas of the skin near the acupuncture points, but not at the acupoints exactly.
The acupuncture needles or placebo needles will be placed immediately before the TEE procedure,
retained in situ during the diagnostic procedure, and will be taken out after the TEE probe is withdrawn.
Before the needle’s insertion, the skin will be completely disinfected with alcohol swabs.
2.6. Outcome Measures
The intensity of gagging, reported by the patient using the verbal rating scale (VRS-11) from 0 = no
gagging to 10 = maximally uncomfortable under gagging, was chosen as a primary outcome measure
(Supplementary Figure S1). The incidence of gagging, nausea and vomiting, reported by the patient,
will be recorded as secondary outcomes. Patients will also be asked about the intensity of nausea,
using VRS-11 (from 0 = no nausea at all to 10 = maximal uncomfortable nausea). The practitioner
who performs the TEE procedure will assess the intensity of gagging using VRS-11 (from 0 = no
gagging at all to 10 = maximal gagging), record the requirement of midazolam and propofol as a rescue
medication, and record the heart rate and oxygen saturation and potential side effects of acupuncture.
Patients’ satisfaction with relief of unwanted side effects during TEE procedure will be evaluated using
VRS-5 (from 1 = excellent to 5 = unsatisfactory); both patients and practitioners (TEE examiner) will be
interviewed regarding their opinion of group allocation.
2.7. Sample Size
In order to calculate the appropriate sample size, we set the level of significance to 0.05 and power
at 80%. Based on the results of investigation published by Rösler et al. [9] and expecting to find a 30%
difference in gagging intensity between the acupuncture group and placebo group (with standard
deviation 50% from mean value) the number of patients was calculated to be 25 per group. Expecting a
drop-out rate of up to 15% in clinical trials, the number of patients per group was inflated to 30, in
total 60 patients for the investigation. For sample size calculation, the online software (free access) was
used [14].
2.8. Data Analysis
Normally distributed continuous data will be compared using the Student’s t-test and an analysis
of variance, as appropriate. Skewed data will be compared using Kruskall–Wallis and Friedman test.
Chi-square test will be used to analyze the incidence of gagging and rescue midazolam application and
the success of patients’ blinding. Statistical analysis will be performed using the software Statistical
Package for Social Science, version 22.0 (SPSS, IBM Corporation, New York, NY, USA).
3. Discussion
In this protocol, we describe a prospective randomized, patient, practitioner and assessor-blinded,
single-center trial, which will compare real acupuncture with a placebo procedure in addition to
current standard therapy for the treatment of gagging during transesophageal echocardiography (TEE).
The aim of this pragmatic clinical investigation is to develop an effective, easily applied method to
relieve the gag reflex using needling of acupoints CV24 and PC6 in patients scheduled for ambulatory
TEE for cardiologic diagnostics.
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Gagging during TEE is extremely unpleasant for patients and may disturb the TEE-examiner, who
is trying to perform a safe and effective diagnostic procedure [15]. Premedication with midazolam was
shown to improve patient comfort during and after TEE [16], however, extensive use of sedatives is
associated with prolonged sedation, delayed recovery and the need for prolonged observation prior to
safe discharge for ambulatory patients [17]. Acupuncture could be a safe and easily applied method to
avoid pharmacological sedation in patients scheduled for an ambulatory TEE procedure.
In this project, we will use intradermal fixed needles for acupuncture during the TEE procedure for
the first time. According to our experience, the practitioner, performing TEE, often comes into contact
with long acupuncture needles placed at acupoint CV24, which is situated in the mentolabial groove
(Figure 1). These accidental contacts may cause a painful reaction, which leads to the uncontrolled
movement of patients during TEE examination. Thus, we have decided to use intradermal needles,
which will not disturb the TEE examination (manipulation with TEE probe in the perioral area).
The combination of two acupoints, CV24 and PC6, which is used for the first time for this
indication, will allow the relief of both gagging and nausea during TEE. From a practical point of view,
the use of only two acupoints to relieve the gag reflex promises to be easier in clinical routine than the
acupuncture of 10 various acupoints, which was reported in a previous trial for the treatment of stress
and gagging in patients undergoing gastroscopy [18].
Although we have based our choice of control condition on experts’ recommendations for the
optimal control procedures for clinical acupuncture trials [19], the use of a physiologically inactive
placebo control condition may introduce at least two sorts of bias into the present investigation: (i) the
inactive placebo condition lacks the unspecific physiological effect that might indirectly enhance the
measured specific effect of acupuncture measured vs. inactive placebo only [20]; (ii) probably it is
likely that some participants who will randomly receive the New Pyonex placebo needles will be
able to distinguish them from real acupuncture, despite the use of tip pressure from the neural pen,
which imitates the pricking sensation. Nevertheless, we will carefully monitor this important aspect
during our investigation, interviewing the patients and practitioners about their opinion regarding the
group allocation.
In conclusion, we describe a proposal for a prospective randomized, patient, practitioner and
assessor-blinded, single-center trial with two arms/groups: real acupuncture will be compared to
placebo acupuncture as an addition to the current standard therapy.
Trial Status
The participants are currently being recruited for the present study.
Supplementary Materials: The following are available online at http://www.mdpi.com/2305-6320/7/4/17/s1,
Figure S1: Schedule of enrollment, interventions and assessment.
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